Product Program year 2025 Source: CMS Open Payments

Cysto-Nephro Videoscope

Device Urology Gynecology

PDI 04953170411250

Open in the dashboard

General payments

$536,302

848 payments

Research payments

$0

0 payments

Through program year 2025, $536,302 in general payments and $0 in research payments were reported against Cysto-Nephro Videoscope (Urology Gynecology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $253,541 244
2024 General $89,002 239
2023 General $39,901 144
2022 General $98,304 121
2021 General $55,555 100

Breakdown

Who paid General payments · program years 2021–2025
  1. Olympus America Inc. $406,739 390 payments
  2. Olympus Corporation of the Americas $128,103 456 payments
  3. Gyrus ACMI, Inc. $1,460 2 payments
Top recipients General payments · program year 2025
  1. Park Nicollet Methodist Hospital Teaching hospital · MN $167,567 66% · 1 payment
  2. Ellis Hospital Teaching hospital · NY $14,787 6% · 1 payment
  3. Mount Sinai Hospital Teaching hospital · NY $14,004 6% · 1 payment
  4. Joshua Meeks Urology · Chicago, IL $11,905 5% · 19 payments
  5. Bernard Bochner Urology · New York, NY $11,221 4% · 15 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Urology $40,277 98% · 69 practitioners
  2. Obstetrics & Gynecology $265 <1% · 2 practitioners
  3. Gynecology Obstetrics & Gynecology $132 <1% · 1 practitioner
  4. Orthopaedic Surgery $132 <1% · 1 practitioner
  5. Physician Assistant $112 <1% · 4 practitioners

The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Minnesota $167,592 66% · 2 recipients
  2. New York $60,822 24% · 13 recipients
  3. Illinois $12,853 5% · 7 recipients
  4. Iowa $2,583 1% · 1 recipient
  5. Missouri $1,885 <1% · 10 recipients

The top 5 of 26 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

848 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record